Nicholas Investment Partners, LP Twist Bioscience Corp Transaction History

Nicholas Investment Partners, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$33.44 - $56.56 $1.61 Million - $2.72 Million	48,142 Added 17.7%	320,168 $11.3 Million
Q2 2022 Aug 10, 2022	SELL	$26.2 - $54.0 $205,355 - $423,252	-7,838 Reduced 2.8%	272,026 $9.51 Million
Q1 2022 May 10, 2022	BUY	$38.58 - $83.27 $4.43 Million - $9.56 Million	114,813 Added 69.56%	279,864 $13.8 Million
Q4 2021 Feb 14, 2022	BUY	$75.47 - $135.88 $2.34 Million - $4.21 Million	30,989 Added 23.12%	165,051 $12.8 Million
Q3 2021 Nov 15, 2021	SELL	$95.64 - $131.48 $4.68 Million - $6.43 Million	-48,905 Reduced 26.73%	134,062 $14.3 Million
Q2 2021 Aug 10, 2021	BUY	$88.13 - $142.06 $1.78 Million - $2.87 Million	20,232 Added 12.43%	182,967 $24.4 Million
Q1 2021 May 14, 2021	SELL	$105.48 - $207.97 $1.7 Million - $3.36 Million	-16,140 Reduced 9.02%	162,735 $20.2 Million
Q4 2020 Feb 11, 2021	SELL	$76.64 - $167.89 $6.95 Million - $15.2 Million	-90,645 Reduced 33.63%	178,875 $25.3 Million
Q3 2020 Nov 13, 2020	BUY	$45.46 - $78.79 $10.3 Million - $17.8 Million	225,697 Added 515.02%	269,520 $20.5 Million
Q2 2020 Aug 12, 2020	SELL	$26.4 - $45.3 $1.86 Million - $3.19 Million	-70,349 Reduced 61.62%	43,823 $1.99 Million
Q1 2020 May 13, 2020	BUY	$19.71 - $35.15 $2.25 Million - $4.01 Million	114,172 New	114,172 $3.49 Million

256

66.8M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.32B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.